-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
DMK PHARMACEUTICALS Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2010 to Q1 2023.
- DMK PHARMACEUTICALS Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$1.55M, a 77.8% increase year-over-year.
- DMK PHARMACEUTICALS Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$25.9M, a 31.5% increase from 2021.
- DMK PHARMACEUTICALS Corp annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$37.8M, a 80.8% decline from 2020.
- DMK PHARMACEUTICALS Corp annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$20.9M, a 5.11% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)